CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  About Us  /  Who we are  /  Biocon’s Business Model

BIOCON’S BUSINESS MODEL IS WOVEN AROUND ITS COMMITMENT TO CORE VALUES

A strategy of being profitably smart and socially good to provide affordable access to advanced biopharmaceuticals for global patient populations.

A motivation to enter niche areas where we perceive the potential to moderate costs and widen patient access.

 A collaborative model that allows us to share risk and reward of drug development through research partnerships and extend our global footprint through local marketing alliances.

A business philosophy built around the core values of quality, affordability, reliability and innovation.

An unwavering commitment to stringent quality controls in compliance with best-in-class global standards.

A relentless focus on chronic disease spaces like diabetes, cancer and autoimmune / inflammation.

A portfolio approach focused on chronic disease segments and integrating well validated target-to-clinic-to-counter capabilities.

An obligation to develop affordable blockbuster drugs with the potential to benefit a billion patients.

Share
Previous Next
Close
Test Caption
Test Description goes like this